J Yeungnam Med Sci.  2024 Apr;41(2):103-112. 10.12701/jyms.2023.01389.

DA-6034 ameliorates hepatic steatosis and inflammation in high fat diet-induced obese mice

Affiliations
  • 1Astrogen Inc., Daegu, Korea
  • 2The East Coast Research Institute of Life Science, Gangneung-Wonju National University, Gangneung, Korea
  • 3Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
  • 4Research Institute of Metabolism and Inflammation, Yonsei University Wonju College of Medicine, Wonju, Korea
  • 5Department of Clinical Research, Vaccine Center for Assisting Safety & Technology, Hwasun, Korea

Abstract

Background
Nonalcoholic fatty liver disease (NAFLD) is characterized by an increase in hepatic triglyceride content and increased inflammatory macrophage infiltration through the C-C motif chemokine receptor (CCR) 5 pathway in the liver. DA-6034 (7-carboxymethyloxy-3',4',5-trimethoxy flavone), is a synthetic derivative of eupatilin that exhibits anti-inflammatory activity in inflammatory bowel disease. However, the effect of DA-6034 on the inflammatory response in NAFLD is not well elucidated. Therefore, we aimed to determine the effect of DA-6034 on hepatic steatosis and inflammation.
Methods
Forty male C57BL/6J mice were divided into the following four groups: (1) regular diet (RD), (2) RD with DA-6034, (3) high fat diet (HFD), and (4) HFD with DA-6034. All mice were sacrificed 12 weeks after the start of the experiment. The effects of DA-6034 on macrophages were assessed using RAW264.7 cells.
Results
DA-6034 not only reduced hepatic triglyceride levels and lipid accumulation but also macrophage infiltration and proinflammatory cytokines in HFD-fed mice. According to fluorescence-activated cell sorter analysis, DA-6034 reduced the CD8+ T cell fraction in the liver of HFD-fed mice. DA-6034 also reduced CCR5 expression and the migration of liver macrophages in HFD-fed mice and inhibited CCR2 ligand and CCR4 ligand, which stimulated the migration of macrophages.
Conclusion
Overall, DA-6034 attenuates hepatic steatosis and inflammation in obesity by regulating CCR5 expression in macrophages.

Keyword

CCR5; DA-6034; Hepatic steatosis; Inflammation; Macrophages
Full Text Links
  • JYMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr